4th European Health Data Protection Congress (EHDPC) 2026

Lawrence Carter and Pippa Parker from the DPO Centre will be speaking at EHDPC 2026, alongside privacy professionals, regulators and experts from across Healthcare and Life Sciences.

The ‘same controller’ restriction: The draft Biotech’s impact on industry

Lawrence Carter, DPO and Life Sciences Sector Lead will explore how the proposed EU Biotech Act could affect the reuse of clinical trial health data, including the potential implications of the new ‘same controller’ gateway for sponsors and trial sites.

Secondary use of clinical trial data: Has the law become clearer?

Pippa Parker, DPO, will examine what recent case law and regulatory guidance on anonymisation, pseudonymisation and scientific research could mean for the compliant reuse of clinical trial data.

The wider EHDPC programme will cover the EHDS, scientific research, AI in healthcare, clinical trials and the evolving health data regulatory landscape.

View the EHDPC 2026 programme